KR20240036634A - 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도 - Google Patents

란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도 Download PDF

Info

Publication number
KR20240036634A
KR20240036634A KR1020247005610A KR20247005610A KR20240036634A KR 20240036634 A KR20240036634 A KR 20240036634A KR 1020247005610 A KR1020247005610 A KR 1020247005610A KR 20247005610 A KR20247005610 A KR 20247005610A KR 20240036634 A KR20240036634 A KR 20240036634A
Authority
KR
South Korea
Prior art keywords
peptide
group
amino acid
disease
absent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247005610A
Other languages
English (en)
Korean (ko)
Inventor
앤드류 기어링
데이비드 켄리
Original Assignee
레터럴 아이피 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2021902267A external-priority patent/AU2021902267A0/en
Application filed by 레터럴 아이피 피티와이 리미티드 filed Critical 레터럴 아이피 피티와이 리미티드
Publication of KR20240036634A publication Critical patent/KR20240036634A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
KR1020247005610A 2021-07-23 2022-07-22 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도 Pending KR20240036634A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2021902267 2021-07-23
AU2021902267A AU2021902267A0 (en) 2021-07-23 Compositions and uses thereof
PCT/AU2022/050778 WO2023000038A1 (en) 2021-07-23 2022-07-22 Peptide compositions capable of binding lanthionine synthetase c-like protein (lancl) and uses thereof

Publications (1)

Publication Number Publication Date
KR20240036634A true KR20240036634A (ko) 2024-03-20

Family

ID=84980448

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247005610A Pending KR20240036634A (ko) 2021-07-23 2022-07-22 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도

Country Status (8)

Country Link
US (1) US20250263435A1 (enExample)
EP (1) EP4373509A4 (enExample)
JP (1) JP2024525959A (enExample)
KR (1) KR20240036634A (enExample)
CN (1) CN117813105A (enExample)
AU (1) AU2022316237A1 (enExample)
CA (1) CA3226259A1 (enExample)
WO (1) WO2023000038A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7751583B2 (ja) * 2019-12-27 2025-10-08 ラテラル、アイピー、プロプライエタリー、リミテッド 環状ペプチド受容体ランチオニンシンテターゼｃ様タンパク質（ｌａｎｃｌ）及びその使用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ981700A0 (en) * 2000-09-01 2000-09-28 Metabolic Pharmaceuticals Limited Product and method for control of obesity
WO2007068039A1 (en) * 2005-12-12 2007-06-21 Metabolic Pharmaceuticals Limited Treatment of weight gain in estrogen deficient mammals
KR20200075044A (ko) * 2008-01-22 2020-06-25 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
CN109983137A (zh) * 2016-08-05 2019-07-05 赛拉预测公司 用于预测暴露于孕激素的怀孕女性的早产的生物标志物
EP3585801A4 (en) * 2017-02-22 2021-05-19 Healthtell Inc. PROCEDURES FOR SCREENING INFECTIONS
CN112218650A (zh) * 2018-01-15 2021-01-12 单侧Ip私人有限公司 肽及其用途
EP3671210A1 (en) * 2018-12-21 2020-06-24 Biosystems International KFT Lung cancer protein epitomic biomarkers
JP7751583B2 (ja) * 2019-12-27 2025-10-08 ラテラル、アイピー、プロプライエタリー、リミテッド 環状ペプチド受容体ランチオニンシンテターゼｃ様タンパク質（ｌａｎｃｌ）及びその使用
RU2731919C1 (ru) * 2020-03-25 2020-09-09 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ коррекции микроциркуляции в плаценте пептидом, имитирующим альфа-спираль B эритропоэтина, при ADMA-подобной модели преэклампсии
RU2751964C1 (ru) * 2021-02-17 2021-07-21 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ снижения агрегационной способности тромбоцитов

Also Published As

Publication number Publication date
CA3226259A1 (en) 2023-01-26
US20250263435A1 (en) 2025-08-21
EP4373509A1 (en) 2024-05-29
WO2023000038A1 (en) 2023-01-26
CN117813105A (zh) 2024-04-02
JP2024525959A (ja) 2024-07-12
AU2022316237A1 (en) 2024-02-01
EP4373509A4 (en) 2025-10-29

Similar Documents

Publication Publication Date Title
ES2773142T3 (es) Nuevo tratamiento
KR20030096227A (ko) 신경 및 신경정신 질환의 치료방법
US20190309021A1 (en) Composition Comprising a Peptide and an Inhibitor of Viral Neuraminidase
CN108472329B (zh) 多肽刺激免疫系统的用途
JP2013234193A (ja) 生理学的過程の調節およびこれに有用な薬剤
CA3045114A1 (en) Modulators of complement activity
KR20240036634A (ko) 란티오닌 합성효소 c-유사 단백질(lancl)에 결합할 수 있는 펩티드 조성물 및 그의 용도
US20230256059A1 (en) Compositions for treating respiratory tract infection and uses thereof
Rujan et al. Calcitonin gene-related peptide antagonists and therapeutic antibodies
CA3129636A1 (en) Triamterene or nolatrexed for use in the treatment of phenylketonuria
US20160128954A1 (en) Methods of Treating Huntington's Disease Using Cysteamine Compositions
US12492223B2 (en) Peptide compositions capable of binding lanthionine synthetase C-like protein (LanCl) and uses thereof
US20230226056A1 (en) Compatible solutes for preventing or treating sars-cov-2 infections
CN115697301A (zh) 用于治疗急性呼吸窘迫综合征、哮喘或变应性鼻炎的制剂和方法
US20250255934A1 (en) Compositions for treating inflammatory airway disease and uses thereof
US11161881B2 (en) Composition comprising a peptide and an inhibitor of viral neuraminidase
US20190233487A1 (en) Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
CA3199479A1 (en) Lipocalin mutein dry powder formulation for treatment of asthma

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240219

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application